Using Practice Facilitation in Primary Care Settings to Reduce Risk Factors for Cardiovascular Disease

Summary

The primary purpose of this study is to evaluate the effectiveness of practice facilitation as a quality improvement strategy for implementing the Million Hearts' ABCS treatment guidelines for reducing cardiovascular disease (CVD) among high-risk patients who receive care in primary care practices in New York City. The ABCS refer to the following: Aspirin in high-risk individuals (A), Blood pressure control and management (B), Cholesterol management (C), and Smoking cessation (S). The long-term goal is to create a robust infrastructure to disseminate and implement evidence based practice guidelines (EBPG) findings in primary care practices and improve practices' capacity to receive and implement other EBPG findings in the future.

Conditions

• Cardiovascular Disease
• High Blood Pressure

Interventions

BEHAVIORAL

Million Hearts ABCS 6 Months

The ABCS refer to the following: Aspirin in high-risk individuals (A), Blood pressure control and management (B), Cholesterol management (C), and Smoking cessation (S).

BEHAVIORAL

Million Hearts ABCS 9 Months

The ABCS refer to the following: Aspirin in high-risk individuals (A), Blood pressure control and management (B), Cholesterol management (C), and Smoking cessation (S).

BEHAVIORAL

Million Hearts ABCS 12 Months

The ABCS refer to the following: Aspirin in high-risk individuals (A), Blood pressure control and management (B), Cholesterol management (C), and Smoking cessation (S).

BEHAVIORAL

Million Hearts ABCS 15 Months

The ABCS refer to the following: Aspirin in high-risk individuals (A), Blood pressure control and management (B), Cholesterol management (C), and Smoking cessation (S).

BEHAVIORAL

Standard Care Regimen 9 Months

BEHAVIORAL

Standard Care Regimen 12 Months

BEHAVIORAL

Standard Care Regimen 15 Months

BEHAVIORAL

Standard Care Regimen 18 Months

BEHAVIORAL

Standard Care Regimen 21 Months

BEHAVIORAL

Standard Care Regimen 24 Months

BEHAVIORAL

Standard Care Regimen 27 Months

BEHAVIORAL

Follow Up Post Intervention 21 Months

BEHAVIORAL

Follow Up Post Intervention 24 Months

BEHAVIORAL

Follow Up Post Intervention 27 Months

BEHAVIORAL

Follow Up Post Intervention 30 Months

BEHAVIORAL

Follow Up Post Intervention 33 Months

Sponsors & Collaborators

• Agency for Healthcare Research and Quality (AHRQ)

  collaborator FED

• NYU Langone Health

  lead OTHER

Principal Investigators

• Donna Shelley, MD · New York University Medical School

Study Design

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

DOUBLE

Model

CROSSOVER

Eligibility

Min Age

18 Years

Max Age

85 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2015-08-31

Primary Completion

2019-04-01

Completion

2019-04-01

Countries

• United States

Study Locations